3701-55-04 Notification prior to screening.

(A) Prior to collecting the blood specimen for screening, the person designated in the applicable provision of this rule shall give each newborn child's parent, legal guardian, or legal custodian, notice of the screening to be conducted by providing printed information describing the newborn genetic, endocrine and metabolic screening program.

(1) When a birth occurs in a hospital, the hospital shall provide the information;

(2) When a birth occurs in a freestanding birthing center, the freestanding birthing center shall provide the information;

(3) When a birth occurs outside a hospital or freestanding birthing center, the attending physician, the certified nurse midwife, the certified nurse practitioner or the clinical nurse specialist shall provide the information;

(4) If there is no physician, certified nurse midwife, certified nurse practitioner or clinical nurse specialist in attendance at the time of birth, upon notification of the birth, the health commissioner of the health district in which the birth occurred shall provide the information.

(B) For purposes of screening for krabbe disease, the designated person as listed in paragraph (A) of this rule shall provide information to the parent, legal guardian, or legal custodian of their right to forgo the screening. If the parent, legal guardian, or legal custodian communicates the decision to forgo this screening, the designated person must document and submit this response to the bureau of public health laboratory in a manner prescribed by the director.

(C) The director shall provide the printed information required by this rule to hospitals, freestanding birthing centers, health commissioners, physicians, certified nurse midwives, certified nurse practitioners and clinical nurse specialists.

(D) The director shall conduct educational programs for hospital and freestanding birthing center newborn screening coordinators, physicians, certified nurse midwives, certified nurse practitioners and clinical nurse specialists, nurses, laboratory staff and others involved in the collection and follow-up of newborn screening specimens.

Effective: 7/1/2016
Five Year Review (FYR) Dates: 11/15/2018
Promulgated Under: 119.03
Statutory Authority: 3701.501
Rule Amplifies: 3701.501
Prior Effective Dates: 3/17/2003 (Emer.), 6/15/03, 8/16/04